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Absa'aet Treatment of cultured ceils with sodium butyrate, that is the histone deacetylase inhibitor, induces the historic hyperacetylation a d the 
expressions of various mammalian genes without affecting the level of protein synthesis. However, butyrate is a non-specific nhibitor of deacetylase 
because of its effects on various other enzymes and nuclear proteins other than histones. On the other hand, Trichostatin A (TSA) was recently found 
to be a potent and specific inhibitor of histone deacetylase. We examined the effect of TSA on the expression of mouse cytokeratin A (endoA). TSA 
increased endoA expression in F9 ceils, and was efffective at a much lower concentration than sodium butyrate. We also examined the changes of 
chromatin structure induced by the two drugs by a DNase 1-hypersensitivity assay. Both drugs induced the formation of a DNase 1-hypersensitive 
site (DH site) in only the promoter region. The precise mechanism(s) by which the two drugs increase ndoA gene expression isunknown, but these 
results suggest hat endoA expression is induced by inhibition of histone deacetylase and that the effect is at the transcriptional level. 
Key words: endoA; Trichostatin A; F9; Histone acetylation; Chromatin; DNase 1-hypersensitive site 
1. Introduction 
The mouse endoA gene is a useful model for studies on 
developmental regulation [1,2], and particularly the features of 
chromatin structure that differ in active and inactive genes [3]. 
Transcriptionally competent chromatin differs from the bulk 
of inactive nuclear chromatin in various characteristics. The 
active gene appears to be packaged in forms of nucleosomes 
that are more sensitive than the bulk of  nucleosomes to diges- 
tion by DNase I [4]. Moreover, transcriptionally active chroma- 
tin is more soluble than inactive chromatin in various buffers, 
thus allowing fractionation of chromatin into active and inac- 
tive components [5,6]. The increased solubility of transcription- 
ally active chromatin suggests partial unwinding or loosening 
of nucleosome-nucleosome int ractions, reflecting a more open 
conformation. The loosening of  the chromatin structure in 
transcribed regions is thought to be due to rapid, transient 
acetylation and deacetylation of histones, and results by vari- 
ous experimental pproaches have shown that histone acetyla- 
tion is correlated with transcription [7-9]. 
Sodium butyrate, an inhibitor of histone deacetylase, en- 
hances the extent of histone acetylation, which has been corre- 
lated with modifications of  the chromatin structure and in- 
creased susceptibility to digestion by DNase I or micrococcal 
nuclease [10,11]. Sodium butyrate has been used to induce dif- 
ferentiated functions in a variety of cell culture systems [12,13] 
and induces selective transcriptional ctivation of some genes 
[13,14]. These activations seem to be due to its effect on histone 
deacetylase. However, experiments using sodium butyrate at a 
high concentration i  vivo must be interpreted with caution 
because this compound not only blocks histone deacetylase but 
also inhibits the phosphorylation of histories and influences the 
phosphorylation of nuclear proteins [15]. Recently, the fungis- 
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tatic antibiotic trichostatin A (TSA) has been shown to be a 
potent, specific inhibitor of histone deacetylase, inhibiting the 
enzyme activity at a nanomolar concentration [16] and activat- 
ing a plaminogen activator gene in F9 cells [17]. 
To elucidate the role of  histone hyperacetylation in the regu- 
lation of gene expression, weexamined the correlation between 
expression of the mouse endoA gene and chromatin structure 
in cultured F9 cells in the presence and absence of the histone 
deacetylase inhibitor TSA. 
2. Materials and methods 
2.1. Cell culture 
F9 cells were cultured in Dulbecco's modified Eagle's medium with 
10% fetal calf serum on gelatin-coated culture dishes. All cultures were 
supplemented with 5 mM glutamine/10 units penicillin/0.5/tg strepto- 
mycin per ml. For treatment with trichostatin A (TSA) or sodium 
butyrate, F9 cells were plated at a density of 2 x 106 cells/100 mm dish 
and 24 h later, TSA and sodium butyrate, r spectively, were added at 
final concentrations of 30 nM and 5 mM. Cells were harvested after 
1 day for DNase I-hypersensitivity assay. 
2.2. RNA isolation and analysis 
Cells were plated at 8 x 105 cells/100 mm dish, and after incubation 
for 24 h, were exposed to 30 nM TSA or 5 mM sodium butyrate for 
various times. Total cellular RNA was extracted with guanidinium 
isothiocyanate followed by centrifugation in cesium chloride solution 
according to a standard method [18]. Samples of 20/lg of RNA per lane 
were separate by electrophoresis in 1.2% agarose gel containing 2.2 M 
formaldehyde [18] and then transferred to nylon membranes in 20 x 
SSC. The blots were hybridized to 32P-labeled endoA cDNA [19]. 
2.3. Preparation fnuclei 
Nuclei from F9 cells were purified by a modification of the method 
of Oshima et al. [20]. Monolayers were washed with cold phosphate- 
buffered saline (PBS), scraped into cold PBS, and collected by centrif- 
ugation for 10 min at 1,000 rpm. Subsequent s eps were carried out at 
0-4°C. The pellet was resuspended in lysis buffer (0.25 M sucrose, 
0.45% Nonidet P-40, 10 mM Tris-HCl (pH 7.5), 10 mM NaCI, 5 mM 
MgCI2, 0.1 mM EGTA, and 0.1 mM phenyl-methylsulfonyl fluoride 
(PMSF)). After vigorous vortexing for 10 s, the mixture was stood at 
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Fig. 1. Effect of TSA on the morphology of F9 cells. Cells were inoculated at 5 x 105 cells per 100-mm culture dish. One day later, TSA was added 
at 30 nM, and the morphology of the cells was observed 24 h later. (A) control; (B) with 30 nM TSA. 
0°C for 15 min, and then, nuclei were pelleted by centrifugation at1,500 
rpm for 5 rain, and resuspended in lysis buffer. The nuclear suspension 
was centrifuged at 1,300×g for 10 min through a cushion of 30% 
sucrose in 10 mM Tris-HCl (pH 7.5), 10 mM NaCI, and 3 mM MgCI 2. 
The nuclear fraction was washed once with suspension buffer (10 mM 
Tris-HCl (pH7.5), 10 mM NaCI, 3 mM MgC12, and 0.1 mM CaCI2), 
precipitated by low-speed centrifugation and resuspended in the same 
buffer at a concentration of 2 × 108 nuclei per ml. 
2.4. DNase 1-hypersensitivity assay 
Determination of DNase 1-hypersensitive site was carried out as 
describded [3]. Nuclei (107/200/.tl) were treated with increasing concen- 
trations of DNase I (Worthington Biochemicals, DPFF grade) for 
5 min at 25°C, and the reaction was terminated by adding final concen- 
trations of 12.5 mM EDTA and 0.25% sodium dodecyl sulfate. The 
mixtures were then treated overnight with 100 pg proteinase K per ml 
at 37°C, followed by phenol/chloroform extraction and ethanol precip- 
itation of the DNA. DNA samples were dissolved in TE buffer (10 mM 
Tris-HC1 (pH 7.5), 1 mM EDTA] and digested with appropriate r stric- 
tion enzymes, and RNA was removed by treatment with 25 pg/ml of 
RNase A. The enzymes were removed by phenol/chloroform extrac- 
tion. The DNA was precipitated with ethanol, dissolved in TE buffer, 
and separated by electrophoresis in 1.2% agarose gel in TAE buffer (40 
mM Tris-acetate (pH 8.0), 1 mM EDTA). It was then transferred to 
nitrocellulose filters (Schleicher&Schuell) and hybridized to specific 
probes labeled with [ct-32p]dCTP (Amersham) by the random primer 
procedure. 
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3.1. Effect of TSA on the morphology of F9 cells 
Previous studies showed that sodium butyrate induced a 
slightly dispersed arrangement of F9 cells, which had a flat, 
polygonal shape [13]. We examined the effect of TSA on the 
morphology of F9 cells. For change in cell morphology, the 
minimum concentration of TSA required was as low as 20 nM 
(data not shown). The morphology of F9 cells after treatment 
with 30 nM TSA for 24 h is shown in Fig. 1. The morphological 
change, that is the same as that of previous report [17], became 
apparent within 6 h after TSA addition. 
3.2. Effect of TSA on expression of the mouse ndoA gene 
The effects of exposure of F9 cells to 30 nM TSA or 5 mM 
sodium butyrate for various times on the expression of endoA 
mRNA were examined by Northern blot analysis (Fig. 2). 
Treatment with TSA markedly enhanced the mRNA level of 
endoA by 8 h after its addition and the increased level persisted 
until at least 24 h after treatment. Sodium butyrate also induced 
endo A expression, as reported previously [13]. 
3.3. Association of induction of the endoA gene by inhibitors of 
deacetylase with an active chromatin configuration 
The mouse endoA gene is 12-kb long and consists of 9 exons 
and 8 introns [21]. We have previously identified an enhancer 
located in the Y-flanking region and shown that in parietal 
yolk-sac-like cells, PYS-2, the promoter is activated by a 3'- 
downstream enhancer [22]. We first examined whether DH sites 
are present within a 2.6-kb EcoRI fragment consisting of the 
5'-flanking region, the first exon, and about half the first intron. 
For  this, nuclei from mouse teratocarcinoma F9 stem cells were 
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Fig. 2. Effects of TSA and sodium butyrate on endoA expression. Cells 
were treated with 30 nM TSA (A) or 5 mM sodium butyrate (B) for the 
indicated times. Cytoplasmic RNAs were isolated and analyzed as 
described in section 2. 
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Fig. 3. DNase I-hypersensitivity in the 5'-end 2.6-kb EcoRI fragment of the mouse endoA gene in stem (A), sodium butyrate-treated (B) and 
TSA-treated (C) F9 cells. Nuclei were treated with DNase I at increasing concentrations i dicated by the rightward arrow (0, 0.02, 0.04, 0.08, and 
0.15 units/ml (panel A); 0, 0.04, 0.08, and 0.15 units/ml (panels B, C)) The EcoRI digest of DNA was separated in 1.2% agarose gel followed by 
hybridized to probe II. Sizes in kb are those of the parental fragment (2.6-kb; thin arrow) and the subfragment obtained by DNase I digestion (1.7-kb; 
thick arrow). The positions of the DH site (downward arrow) and of the probe (stippled box) are shown at the bottom. 
incubated with increasing concentrations of DNase I, and after 
EcoRI  digestion, Southern blotting was performed followed by 
hybridization to probe II. No positive subfragment was de- 
tected, suggesting that no DH site is present in the 2.6-kb EcoRI 
fragment (Fig. 3A). 
We next examined the chromatin structure of the same re- 
gion of F9 cells treated with TSA or sodium butyrate. Probe 
II hybridized to only a 1.7-kb subfragment ofpreparations after 
both treatments (Fig. 3B and C). This DH site was located in 
the promoter region. We have reported that probe II hybridizes 
to two subfragments of 1.9-kb and 1.7-kb within this region in 
differentiated F9 cells induced by retinoic acid (RA) and dibu- 
tyryl cAMP [3]. 
Subsequently, the 4-kb BamHI  fragment, containing an en- 
hancer located 1.2-kb downstream from the last exon, was 
examined. This region has no DH site in undifferentiated F9
cells, but one DH site has been identified in the enhancer region 
in differentiated F9 cells (Fig. 4A; see [3]). Nuclei from F9 cells 
treated with TSA or sodium butyrate were incubated with in- 
creasing concentrations of DNase I, and after BamHI diges- 
tion, Southern blotting was performed to probe V. Unexpect- 
edly, we did not detect any subfragrnents (Fig. 4B and C). These 
results suggest hat induction of endoA gene expression by 
inhibitors of histone deacetylase does not cause change of chro- 
matin structure in the enhancer region. 
4. Discussion 
Histone acetylation plays an important role in chromatin 
assembly. There is a close correlation between histone acetyla- 
tion and transcription, and several studies have shown that 
actively transcribed genes are selectively enriched in acetylated 
histones [7-9]. Butyrate has been suggested to be rather un- 
specific inhibitor of histone deacetylase, also affecting some 
other enzymes [14]. Recently TSA, which differs in chemical 
structure from sodium butyrate, was shown to enhance ac- 
cumulation of highly acetylated histones in vivo, and its effect 
was shown to be due to its specific inhibition of histone deace- 
228 
RA/cAMP- t reated  
0 DNase  I : 
F9 Butyrate - t reated  F9 
0. DNase  I ~ _ 
T. Miyashita et aL IFEBS Letters 353 (1994) 225-229 
TSA- t reated  F9 
DNase  I 
0 
kb 
~---- 4 
-91--2.6 
kb 
4- - -4  
kb 
4 
A B C 
I kb 
I I 
1 
BamHI I [ ~ IBamHI 
Exon 9 Enhancer [~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
probe V 
Fig. 4. DNase I-hypersensitivity n the 3'-end 4-kb BamHI fragment of the mouse ndoA gene in retinoic acid (RA) and dibutyryl cAMP-treated (A), 
sodium butyrate-treated (B) and TSA-treated (C) F9 cells. Nuclei were tr ated with DNase I at increasing concentrations indicated by the rightward 
arrow (0, 0.02, 0.04, and 0.08 units/ml (panel A); 0, 0.08, and 0.15 unitdml (panel B); 0, 0.04, 0.08, and 0.15 units/ml (panel C)). The BamHl digest 
of DNA was separated in 1% agarose gel and hybridized to probe V. The positions of the DH site (downward arrow) in the enhancer region f the 
endo A gene in differentiatd F9 cells and of the probe (stippled box) are shown at the bottom. 
tylase [I 6]. We examined the effect of TSA on expression of the 
mouse endoA gene in F9 cells. TSA at 30 nM induced a slightly 
dispersed arrangement of F9 cells similar to that observed on 
their treatment with 5 mM sodium butyrate. This differentia- 
tion-like morphological change of the cells was associated with 
induction of endoA mRNA synthesis. Thus we assume that 
inhibition of histone deacetylase activity caused both morpho- 
logical change of F9 cells and induction of endoA mRNA. 
We also examined the changes in chromatin structure associ- 
ated with activation of this gene. In a 12-kb genomic fragment 
carrying the mouse endoA gene, a DNase I-hypersensitive site 
was found only in the promoter region in cells treated with TSA 
or butyrate. This result is consistent with the general observa- 
tion that regions around the promoter of genes that are active 
are DNase I-hypersensitive [23]. The precise mechanism(s) by 
which the two drugs increase ndoA expression isstill unknown, 
but these results suggest hat endoA expression is caused by 
inhibition of histone deacetylase and that the effect(s) is at the 
transcriptional level. We could not detect any DH site located 
upstream of the promoter or in the enhancer region. We do not 
know why treatment with the histone deacetylase inhibitor does 
not confer the active chromatin configuration on both regions, 
as observed in differentiated F9 cells induced by retinoic acid 
(RA) and dibutyryl cAMP. Tazi and Bird reported that CpG 
islands, which are involved in the 5' end of all known house- 
keeping enes, contain histones H3 and H4 in a highly acetyl- 
ated form [24]. Since the region of the upstream of the promoter 
and the enhancer does not contain CpG islands [21], the ab- 
sence of CpG islands may not guarantee the formation of 
highly acetylated chromatin. Alternatively, TSA may affect the 
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formation of a DH site by preventing nucleosome displacement 
due to histone hyperacetylation [25-27]. Another possibility is 
that TSA-induced expression of endoA gene is excuted through 
an independent pathway from the retinoic acid- induced expres- 
sion. 
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